PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PixarBio Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10950
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PixarBio Corp (PixarBio), formerly BMP Holdings Inc is a biotechnology company that discovers and develops novel neurological drug delivery systems for postsurgical pain, acute pain, and chronic pain. The company offers research and commercial development of targeted drug delivery systems, biologics and devices to treat Parkinson’s disease, pain, epilepsy, and spinal cord injury. Its lead product platform NeuroRelease facilitated the sustained release of non-addictive and non-opiate drugs in post-operative, acute and chronic pain in pre-clinical models. PixarBio also helps reduce pain signals without impeding locomotion signals. The company has its operations in New Jersey, New York, and New Hampshire, the US. PixarBio is headquartered in Fort Lee, New Jersey, the US.

PixarBio Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PixarBio Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PixarBio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PixarBio Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PixarBio Raises USD7.2 Million in Venture Financing 10
Merger 11
BMP Holdings Merges with PixarBio in Reverse Merger Transaction 11
Equity Offering 12
Pixarbio Raises USD0.4 Million in Private Placement 12
PixarBio Raises USD0.8 Million in Financing 13
PixarBio Raises USD7.2 Million in Private Placement of Shares and Warrants 14
PixarBio Corp – Key Competitors 15
PixarBio Corp – Key Employees 16
PixarBio Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
01/27/2017: PixarBio CEO Frank Reynolds to Present NeuroRelease a Morphine Replacement, Non-Opiate, Non Addictive Pain Treatment at the 2017 NobleCon13 Investor Conference in Boca Raton, FL on Monday, January 30, 2017 18
01/09/2017: PixarBio Expands Non-Opiate R&D Portfolio For Pain with Steroid Injections; Collaborates for Clinical cGMP Manufacturing, and Grooms Team For Clinical Studies of NeuroRelease Post-Surgical Pain Treatments 14-Day, 7-Day, and 3-Day 19
01/05/2017: PixarBio CEO Frank Reynolds to Present NeuroRelease a Morphine Replacement, Non-Opiate, Non Addictive Pain Treatment at the 2017 Biotech Showcase in San Francisco 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
PixarBio Corp, Pharmaceuticals & Healthcare, Key Facts 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PixarBio Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PixarBio Corp, Deals By Therapy Area, 2012 to YTD 2018 8
PixarBio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PixarBio Raises USD7.2 Million in Venture Financing 10
BMP Holdings Merges with PixarBio in Reverse Merger Transaction 11
Pixarbio Raises USD0.4 Million in Private Placement 12
PixarBio Raises USD0.8 Million in Financing 13
PixarBio Raises USD7.2 Million in Private Placement of Shares and Warrants 14
PixarBio Corp, Key Competitors 15
PixarBio Corp, Key Employees 16
PixarBio Corp, Other Locations 17
PixarBio Corp, Subsidiaries 17

List of Figures
PixarBio Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PixarBio Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prime Healthcare Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prime Healthcare Services Inc (Prime Healthcare) is a hospital management center that operates acute care hospitals. The center provides medical services such as emergency room, senior services, heart care services, behavioral health services, and others. It offers surgical services, wound h …
  • Yoho Resources Inc. (YO)-石油・ガス分野:企業M&A・提携分析
    Summary Yoho Resources Inc. (Yoho) is an upstream oil and gas exploration company. The company carries out exploration, development and production of crude oil and natural gas liquid, and natural gas. The company has operations within the Western Canadian Sedimentary Basin focusing exploration activ …
  • Punjab National Bank:企業の戦略・SWOT・財務分析
    Punjab National Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Williams-Sonoma, Inc.:企業の戦略・SWOT・財務情報
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • U.S. Preventive Medicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary U.S. Preventive Medicine Inc (USPM) is a healthcare service center that provides wellness and care management services. The center offers preventive plan, a web-based or online health management platform for the clinical science of preventive medicine. Its preventive plan library provides in …
  • X4 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary X4 Pharmaceuticals Inc (X4 Pharma) is a clinical stage biotechnology company that develops novel therapeutics to treat cancer and rare diseases. The company’s lead drug candidate, X4P-001-LD, is in Phase 2/3 trial used for the treatment for patients with WHIM and other immunodeficiencies. It …
  • WEC Energy Group Inc (WEC)-エネルギー分野:企業M&A・提携分析
    Summary WEC Energy Group, Inc. (WEC) is a diversified holding company that carries out the generation and distribution of electricity in southeastern Wisconsin, east central Wisconsin, northern Wisconsin, and Michigan's Upper Peninsula; and transports and distributes natural gas in the upper peninsu …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Ingram Micro Inc.:企業の戦略・SWOT・財務情報
    Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Exxon Mobil Corp (XOM):電力:M&Aディール及び事業提携情報
    Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufacturer and …
  • Grupo Aeroportuario del Centro Norte SAB de CV:企業の戦略・SWOT・財務情報
    Grupo Aeroportuario del Centro Norte SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Aeroportuario del Centro Norte SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Gibson Energy Inc (GEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Gibson Energy Inc (Gibson) is an independent midstream energy company. It provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids, water, oilfield waste, and refined products. Gib …
  • Karolinska University Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Karolinska University Hospital (KUH), a subsidiary of Karolinska Institutet is a healthcare service provider that offers patient care, research and education programs. The hospital offers cross border medical care by referring patients or by tele medicine and health care at a distance. It of …
  • Admedes GmbH:企業の戦略的SWOT分析
    Admedes GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • National Grid Plc:発電所・企業SWOT分析
    National Grid Plc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Cerus Corp (CERS):医療機器:M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • NCC Group PLC (NCC):企業の財務・戦略的SWOT分析
    NCC Group PLC (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Exact Holding N.V.:企業の戦略的SWOT分析
    Exact Holding N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Avanti Energy Inc (AVN):石油・ガス:M&Aディール及び事業提携情報
    Summary Avanti Energy Inc (Avanti Energy), formerly Overlord Capital Ltd is an oil and gas exploration and production company. The company acquires, explores and develops gas reserves in Central Italy. It re-develops the existing oil and gas reserves. Avanti Energy re-enters and drills new wells in …
  • Boyd Gaming Corporation:企業の戦略・SWOT・財務分析
    Boyd Gaming Corporation - Strategy, SWOT and Corporate Finance Report Summary Boyd Gaming Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆